Target intelligence / Profile preview

TLC domain-containing protein 4 (TLCD4)

Target: TLCD4
Molecular classification: Other, Transmembrane protein

Overview

TLC domain-containing protein 4 (TLCD4) is a predicted transmembrane protein localized primarily to membranes such as the endoplasmic reticulum, and is postulated to be involved in lipid homeostasis. There is little evidence supporting its role as a direct therapeutic target, receptor, enzyme, or transporter. Mutations in TLCD4 have been associated with hypertrophic cardiomyopathy. No drugs, biomarkers, or established therapeutic relevance currently exist for TLCD4[1][3][7].

Other names: TMEM56FLJ31842Transmembrane protein 56TLC domain containing 4TLCD4transmembrane protein 56

Biological functions

Lipid homeostasis

Disease associations

Hypertrophic cardiomyopathy

Beyond the preview

Go deeper on TLC domain-containing protein 4 (TLCD4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TLC domain-containing protein 4 (TLCD4).

Explore the full profile